Expression of V beta gene segments by Sezary cells.

Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol (2011) 1.85

Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma. Toxins (Basel) (2013) 0.91

Failure of anti-T-cell receptor V beta antibodies to consistently identify a malignant T-cell clone in Sézary syndrome. Am J Pathol (1996) 0.81

CD158K/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of Sézary syndrome. J Invest Dermatol (2007) 0.81

Histopathologic diagnosis of lymphomatous versus inflammatory erythroderma: a morphologic and phenotypic study on 47 skin biopsies. Am J Dermatopathol (2010) 0.75

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science (2003) 19.77

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia (2003) 7.04

Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol (2003) 3.66

European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol (2009) 3.56

Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). Br J Dermatol (2007) 2.85

The MLL recombinome of acute leukemias in 2013. Leukemia (2013) 2.55

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia (2007) 2.40

Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood (1994) 2.01

High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma. Arch Dermatol (1995) 2.00

Are complicated forms of celiac disease cryptic T-cell lymphomas? Blood (1998) 1.87

The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Proc Natl Acad Sci U S A (1989) 1.86

Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res (1998) 1.80

The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol (2001) 1.79

Chronic radiodermatitis following cardiac catheterisation: a report of two cases and a brief review of the literature. Heart (1999) 1.78

Leg ulcers and hydroxyurea: forty-one cases. Arch Dermatol (1999) 1.77

Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. Blood (2000) 1.59

Long-term safety of cyclosporine in the treatment of psoriasis. Arch Dermatol (1996) 1.58

Corneal endothelial cell apoptosis in patients with Fuchs' dystrophy. Invest Ophthalmol Vis Sci (2000) 1.57

Screening human donor corneas during organ culture for the presence of guttae. Br J Ophthalmol (2001) 1.56

Neutrophilic dermatoses during granulocytopenia. Arch Dermatol (1995) 1.56

Expression and prognostic significance of survivin in de novo acute myeloid leukaemia. Br J Haematol (2000) 1.56

The clinicopathological features of extensive small intestinal CD4 T cell infiltration. Gut (1999) 1.54

A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis. Br J Dermatol (2002) 1.52

Ciclosporin in psoriasis clinical practice: an international consensus statement. Br J Dermatol (2004) 1.51

Cloning and characterization of the murine toll-like receptor 5 (Tlr5) gene: sequence and mRNA expression studies in Salmonella-susceptible MOLF/Ei mice. Genomics (2000) 1.49

The reconstitution of living skin. J Invest Dermatol (1983) 1.49

Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood (1997) 1.48

[Intravenous pulse methylprednisolone therapy for severe alopecia areata: an open study of 66 patients]. Ann Dermatol Venereol (2003) 1.47

Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med (1990) 1.46

Evidence of a marked 25-hydroxyvitamin D deficiency in patients with congenital ichthyosis. J Eur Acad Dermatol Venereol (2006) 1.45

Cyclosporin A inhibits the antigen-presenting functions of freshly isolated human Langerhans cells in vitro. J Invest Dermatol (1991) 1.44

A t(8;14)(q24;q11) translocation in a T-cell leukemia (L1-ALL) with c-myc and TcR-alpha chain locus rearrangements. Int J Cancer (1986) 1.43

Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis. Arch Dermatol (1997) 1.43

Pityriasis rubra pilaris in a patient with human immunodeficiency virus infection. J Am Acad Dermatol (1992) 1.43

T lymphocyte subsets in primary antiphospholipid syndrome. J Rheumatol (1994) 1.43

Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. Genomics (2001) 1.42

[Thalidomide and thrombosis]. Ann Dermatol Venereol (2000) 1.40

Activation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppression. Proc Natl Acad Sci U S A (1996) 1.40

Acral persistent papular mucinosis and IgA monoclonal gammopathy: report of a case. Dermatology (1992) 1.38

High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis. Blood (1990) 1.37

Salmonella enterica serovar typhimurium waaP mutants show increased susceptibility to polymyxin and loss of virulence In vivo. Infect Immun (2000) 1.32

Cell surface phenotype and human T lymphotropic virus type 1 antigen expression in 12 T cell lines derived from peripheral blood and cerebrospinal fluid of West Indian, Guyanese and African patients with tropical spastic paraparesis. J Gen Virol (1990) 1.29

Genetic linkage of recessive dystrophic epidermolysis bullosa to the type VII collagen gene. J Clin Invest (1992) 1.29

Human T cell gamma genes are frequently rearranged in B-lineage acute lymphoblastic leukemias but not in chronic B cell proliferations. J Exp Med (1987) 1.28

Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol (1996) 1.28

Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol (2012) 1.26

Donor organ cultured corneal tissue selection before penetrating keratoplasty. Br J Ophthalmol (1998) 1.23

Haploinsufficiency of the IKZF1 (IKAROS) tumor suppressor gene cooperates with BCR-ABL in a transgenic model of acute lymphoblastic leukemia. Leukemia (2010) 1.22

Regulation of transcription of the human T cell antigen receptor delta chain gene. A T lineage-specific enhancer element is located in the J delta 3-C delta intron. J Exp Med (1990) 1.22

Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes. J Invest Dermatol (1989) 1.21

Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol (1991) 1.21

A model for tumor suppression using H-1 parvovirus. Proc Natl Acad Sci U S A (1993) 1.20

A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy. J Clin Endocrinol Metab (2003) 1.20

Peripheral selection of V delta 1+ cells with restricted T cell receptor delta gene junctional repertoire in the peripheral blood of healthy donors. J Exp Med (1993) 1.20

Association of Mycoplasma penetrans with human immunodeficiency virus infection. J Infect Dis (1995) 1.20

Autosomal recessive lamellar ichthyosis: identification of a new mutation in transglutaminase 1 and evidence for genetic heterogeneity. Hum Mol Genet (1995) 1.20

Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro. Science (1985) 1.18

Transgenic mice for MTCP1 develop T-cell prolymphocytic leukemia. Blood (1998) 1.18

Cellular immune response in Echinococcus multilocularis infection in humans. II. Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis. Clin Exp Immunol (1989) 1.17

The MTCP-1/c6.1B gene encodes for a cytoplasmic 8 kD protein overexpressed in T cell leukemia bearing a t(X;14) translocation. Oncogene (1994) 1.17

Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation. Blood (1994) 1.15

MTCP-1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor alpha/delta locus in mature T cell proliferations. Oncogene (1993) 1.14

Mapping of Papillon-Lefevre syndrome to the chromosome 11q14 region. Eur J Hum Genet (1997) 1.13

Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias. Leukemia (2006) 1.12

Molecular characterization of a human tyrosinase-related-protein-2 cDNA. Patterns of expression in melanocytic cells. Eur J Biochem (1994) 1.12

Endophthalmitis after Lasiodiplodia theobromae corneal abscess. Graefes Arch Clin Exp Ophthalmol (1997) 1.11

No germline ATM mutation in a series of 16T-cell prolymphocytic leukemias. Blood (2000) 1.11

Inactivation of the ATM gene in T-cell prolymphocytic leukemias. Blood (1998) 1.10

Prevalence and distribution of ringed sideroblasts in primary myelodysplastic syndromes. J Clin Pathol (1983) 1.09

Morphology, histology, and ultrastructure of human C31 organ-cultured corneas. Cornea (1995) 1.09

Genomic alterations of the p19ARF encoding exons in T-cell acute lymphoblastic leukemia. Blood (1998) 1.07

Cell survival and shuttle vector mutagenesis induced by ultraviolet A and ultraviolet B radiation in a human cell line. J Invest Dermatol (1996) 1.07

Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study. Leukemia (2006) 1.07

Down-regulation of human granzyme B expression by glucocorticoids. Dexamethasone inhibits binding to the Ikaros and AP-1 regulatory elements of the granzyme B promoter. J Biol Chem (1998) 1.06

A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients. Hematol J (2001) 1.06

Non-coherent near infrared radiation protects normal human dermal fibroblasts from solar ultraviolet toxicity. J Invest Dermatol (1998) 1.06

Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. Blood (1996) 1.06

Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy. Leukemia (2002) 1.05

A complex pattern of recurrent chromosomal losses and gains in T-cell prolymphocytic leukemia. Genes Chromosomes Cancer (2001) 1.05

Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes. J Invest Dermatol (1990) 1.04

Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias. J Clin Invest (1990) 1.04

Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity. J Eur Acad Dermatol Venereol (2011) 1.04

HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol (2001) 1.04

Resistance of Acanthamoeba to classic DNA extraction methods used for the diagnosis of corneal infections. Br J Ophthalmol (2007) 1.03

UVA-induced lipid peroxidation in cultured human fibroblasts. Biochim Biophys Acta (1991) 1.03

A Th0/Th2-like function of CD4+CD7- T helper cells from normal donors and HIV-infected patients. J Immunol (1995) 1.03

Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic Leukemia. Blood (1994) 1.03

Cytogenetic studies on 519 consecutive de novo acute nonlymphocytic leukemias. Cancer Genet Cytogenet (1987) 1.02

A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity. Br J Dermatol (2007) 1.02

Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol (2012) 1.02